By Josh White
Date: Thursday 14 Dec 2023
(Sharecast News) - Medical cannabis specialist Celadon Pharmaceuticals has started supplying its pharmaceutical-grade product to two commercial contracts, first announced on 24 May and 5 September, it said on Thursday.
Product Supplied to First Two Sales Contracts | 14-Dec-2023 | 07:00 | RNS |
Fundraise, Update on Future CLN Financing & TVR | 12-Dec-2023 | 14:00 | RNS |
New European Sales Contract | 16-Nov-2023 | 07:00 | RNS |
Fundraise, CLN Issue, Joint Broker Appointed & TVR | 13-Oct-2023 | 07:00 | RNS |
Interim Results | 28-Sep-2023 | 07:00 | RNS |
No recent information was found.
No recent information was found.
No recent information was found.
Currency | UK Pounds |
Share Price | 84.00p |
Change Today | 1.50p |
% Change | 1.82 % |
52 Week High | 175.00 |
52 Week Low | 80.00 |
Volume | 6,429 |
Shares Issued | 64.21m |
Market Cap | £53.94m |
RiskGrade | 111 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:35 | 503 @ 84.00p |
16:35 | 503 @ 84.00p |
15:40 | 5 @ 85.00p |
15:40 | 11 @ 85.00p |
15:40 | 58 @ 85.00p |
CEO | James Short |
CFO | Jonathan Turner |
You are here: research